European Medicines Agency’s Post

View organization page for European Medicines Agency, graphic

311,165 followers

📢 Exciting news for medical device manufacturers! EMA has launched a pilot programme to support the development and assessment of orphan #MedicalDevices offering free advice and guidance about their clinical evaluation. Orphan devices are medical devices or accessories used for diseases or conditions affecting only a small number of individuals each year. Find out how you can join this new pilot here 👉 https://lnkd.in/dcsvryJu

  • No alternative text description for this image

Excellent news! To me this pilot program represents a new hope for patients suffering from rare disorders. To me also this program should be part of the orphan drug regulation. It has been an honnor for me to represent Belgium in the COMP since the first meeting and during 17 years.

Tamsyn F.

Innovative Regulatory Strategies for Innovative Products | Specialist EU Representation

2mo

This is very exciting news for the rare disease community 👏

Like
Reply
Rahmi Oklu MD, PhD, FSIR

Professor, Consultant, Vascular Interventional Radiologist and Director, Laboratory for Patient Inspired Engineering, Mayo Clinic. President and CEO, InTumo Therapeutics Inc.

2mo

This is great!

Like
Reply
Cheng Han-Ni, MS, IPMP - e/acc

ENTJ-A | Pharma Business Process Reengineering|GxP Compliance | Project Management | Serialization Expert | Clinical Trial Associate Scientist | Multilingual (English, Mandarin, Minnan Language)

2mo

This is great

Like
Reply
BAHIZI Marcel, Ph.D.

Market, Pricing and Industial Suport Analyst

2mo

Excellent work

Like
Reply
Elizabeth Gfoeller

Corporate Director, Regulatory Affairs

2mo

Thanks for sharing Alice Forde

Vieri del Sorbo

Senior Manager in Project and Programme Management | Drug Development of Biologics | GMP Manufacture ATMPs | Change and Strategy Management

2mo

Great news Lorenzo Pio Serino

Like
Reply
Jin Y.

Market Access and Outcome Strategy/Medical Communication Scientist

2mo

Good news!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics